Stock Ratings / Health Care / PTCT / forecast

LLY (72) JNJ (66) ABBV (71) UNH (70) ⌘ Pro Terminal →

PTC Therapeutics Inc. (PTCT) 12-Month Stock Forecast & Price Target Cone

$64.46 +2.29% NASDAQ • Public Delayed / 60s Snapshot

PTC Therapeutics Inc. (PTCT) earns a Roarable Rating of B- (Buy) with 70/100 RQD Confidence. High-quality cash engine (41% profit margin, 85% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.

ROARABLE B- • BUY Cap $5.38B

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B-

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

5-PILLAR SNOWFLAKE RADARRw C · Rk B+

Each axis scored 0–20

12M PRICE TARGET CONE+5.4% Base Target

WHALE OPTIONS TUG-OF-WAR:58% Call Buyers ($2.6M)

42% PutsMax Pain: $63.00

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your PTCT Position Size: $10,000

Shares at $64.46: 155.1 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $52.86

$8,200

$-1,800 (-18.0%)

12M Consensus BaseTarget $67.94

$10,540

+$540 (+5.4%)

12M Bull Case BreakoutTarget $95.41

$14,801

+$4,801 (+48.0%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (34 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 23● Hold: 9● Sell: 2

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	OUTPERFORM	$71	74%	A
Goldman SachsSector Coverage Lead	BUY	$90	69%	B
JP MorganUS Large-Cap Research	HOLD	$60	58%	C

🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk

Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live PTCT Tape Review)

✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen

RQD INSIDER CLUB UPGRADE$49/YEAR

Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?

🤖 Try AI Indicator Builder ($49/yr VIP) →$100K Arena

PTCT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -7.82%🛡️ HOLDING TREND SUPPORT

2026-10-30O $64.75H $65.34L $59.64C $59.97VOL 2.36M

SUP: $57.47SMA50: $65.36SMA200: $70.67

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

PTCT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 PTCT Butterfly Map → + Track PTCT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

-5.7%/yr Implied 5Y Growth

vs. +114.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on PTCT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for PTCT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for PTCT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

PTCT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is PTCT's 12-month stock price target?

PTC Therapeutics Inc. (PTCT) carries a 12-month consensus base price target of $67.94 (+5.4% from $64.46), with a bull-case target of $95.41 and a bear-case floor of $52.86.

Is PTCT stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates PTCT B- (Buy — BUY) with an RQD Confidence score of 70/100.

Direct Sub-Reports: PTCT RQD Cockpit PTCT 12M Forecast PTCT Earnings & Move PTCT Dividends & DRIP PTCT Insiders & 13F PTCT Whale Options PTCT Profit Sankey PTCT News & Why